ImmunoPrecise Antibodies Ltd. (HYFT) Balance Sheet
HYFT balance sheet, FY2026
April 30, 2026 · Canadian dollarsC$21.3M assets = C$9.6M liabilities + C$11.7M equity
Both columns are drawn to the same scale: what HYFT owns equals what it owes plus shareholders’ equity. Hover a block for its value.
HYFT financial health
Current ratio2.80
Comfortable · current assets cover current liabilities 2.80×
Debt / equity0.30
Low leverage · C$0.30 of debt for each $1 of equity
Equity / assets55.0%
Equity-funded · of assets funded by shareholders
Cash / debt321.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
HYFT balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | C$3.9MFY2017 | C$21.3MFY2026 | +20.7%/yr | |
| Total liabilities | C$836,915FY2017 | C$9.6MFY2026 | +31.2%/yr | |
| Shareholders’ equity | C$3.1MFY2017 | C$11.7MFY2026 | +16.0%/yr | |
| Cash & short-term investments | C$2.6MFY2017 | C$11.3MFY2026 | +17.9%/yr | |
| Total debt | C$3.8MFY2018 | C$3.5MFY2026 | −1.0%/yr | |
| Net cash (debt) | −C$2.0MFY2018 | C$7.8MFY2026 | +C$9.8M | |
| Working capital | C$2.4MFY2017 | C$10.4MFY2026 | +C$8.0M | |
| Current ratio | 3.92FY2017 | 2.80FY2026 | −1.12 | |
| Debt / equity | 0.30FY2018 | 0.30FY2026 | 0.00 | |
| Shares outstanding | 4.0MFY2017 | 46.4MFY2026 | +31.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
HYFT assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
HYFT liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
HYFT debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
HYFT balance sheet in Canadian dollars
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | C$11.3M | C$10.7M | C$3.5M | C$8.3M | C$30.0M | C$41.8M | C$2.6M | C$5.5M | C$1.8M | C$2.6M |
| Cash & equivalents | C$11.3M | C$10.7M | C$3.5M | C$8.3M | C$30.0M | C$41.8M | C$2.6M | C$5.5M | C$1.8M | C$2.6M |
| Short-term investments | — | — | — | — | — | — | C$104 | — | — | — |
| Receivables | C$3.6M | C$4.8M | C$4.1M | C$3.9M | C$3.4M | C$3.6M | C$3.7M | C$2.0M | C$2.2M | C$469,488 |
| Inventory | C$491,168 | C$2.1M | C$2.1M | C$2.1M | C$1.6M | C$1.2M | C$818,643 | C$2.1M | C$412,690 | C$58,499 |
| Other current assets | C$796,653 | C$1.2M | C$1.8M | C$2.6M | C$2.5M | C$2.3M | C$615,093 | C$333,702 | C$342,636 | C$177,959 |
| Total current assets | C$16.2M | C$18.8M | C$11.5M | C$16.8M | C$37.5M | C$48.9M | C$7.7M | C$9.9M | C$4.8M | C$3.3M |
| Property, plant & equipment (net) | C$4.1M | C$16.3M | C$16.7M | C$10.7M | C$3.7M | C$4.1M | C$3.2M | C$1.6M | C$1.6M | C$644,578 |
| Goodwill & intangible assets | C$0 | C$9.3M | C$31.2M | C$50.1M | C$52.1M | C$13.8M | C$16.2M | C$16.7M | C$8.9M | C$0 |
| Long-term investments | C$0 | C$0 | C$0 | C$115,000 | C$142,000 | C$0 | C$0 | C$0 | C$0 | C$0 |
| Other non-current assets | C$1.1M | C$126,000 | C$561,000 | C$86,000 | C$82,000 | C$190,000 | C$204,025 | C$157,854 | C$9.3M | C$0 |
| Total assets | C$21.3M | C$44.4M | C$60.0M | C$77.8M | C$93.5M | C$67.0M | C$27.3M | C$28.3M | C$24.6M | C$3.9M |
| Liabilities | ||||||||||
| Accounts payable | C$4.2M | C$5.3M | C$4.4M | C$2.5M | C$4.8M | C$1.3M | C$1.4M | C$1.6M | C$2.0M | C$664,447 |
| Short-term debt | C$456,226 | C$1.9M | C$1.6M | C$1.9M | C$2.3M | C$1.8M | C$2.9M | C$2.8M | C$195,288 | — |
| Deferred revenue | C$1.1M | C$1.1M | C$1.4M | C$720,342 | C$1.0M | C$1.1M | C$1.5M | C$724,693 | C$317,539 | C$172,468 |
| Total current liabilities | C$5.8M | C$9.0M | C$8.1M | C$5.9M | C$9.3M | C$6.1M | C$7.9M | C$7.2M | C$4.3M | C$836,915 |
| Long-term debt | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 |
| Lease obligations | C$3.5M | C$13.4M | C$13.7M | C$7.3M | C$1.5M | — | — | — | — | — |
| Other long-term liabilities | C$3.8M | C$11.8M | C$17.9M | C$14.1M | C$9.1M | C$4.0M | C$4.2M | C$3.1M | C$7.6M | C$0 |
| Total liabilities | C$9.6M | C$20.8M | C$26.1M | C$20.0M | C$18.4M | C$10.0M | C$12.2M | C$10.3M | C$11.9M | C$836,915 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | C$137.0M | C$136.4M | C$119.8M | C$117.5M | C$114.6M | C$80.1M | C$34.1M | C$32.7M | C$20.5M | C$7.5M |
| Retained earnings (deficit) | −C$142.5M | −C$128.8M | −C$100.3M | −C$73.1M | −C$46.5M | −C$29.8M | −C$22.5M | −C$17.5M | −C$9.7M | −C$4.6M |
| Accumulated other comprehensive income | C$3.1M | C$3.2M | C$2.0M | C$2.6M | −C$2.5M | −C$687,000 | −C$300,222 | −C$228,060 | C$277,090 | −C$737,217 |
| Total shareholders' equity | C$11.7M | C$23.6M | C$33.9M | C$57.8M | C$75.3M | C$56.9M | C$15.1M | C$18.1M | C$12.7M | C$3.1M |
| Key figures | ||||||||||
| Total debt | C$3.5M | C$13.4M | C$13.7M | C$14.3M | C$2.8M | C$4.3M | C$4.5M | C$2.9M | C$3.8M | — |
| Net cash (debt) | C$7.8M | −C$2.7M | −C$10.2M | −C$6.0M | C$27.2M | C$37.5M | −C$1.9M | C$2.5M | −C$2.0M | — |
| Working capital | C$10.4M | C$9.7M | C$3.4M | C$10.9M | C$28.2M | C$42.8M | −C$230,325 | C$2.7M | C$498,377 | C$2.4M |
| Tangible book value | C$11.7M | C$14.3M | C$2.7M | C$7.7M | C$23.2M | C$43.1M | −C$1.1M | C$1.4M | C$3.8M | C$3.1M |
| Shares outstanding | 46.4M | 33.4M | 25.6M | 24.9M | 19.7M | 16.5M | 13.6M | 12.5M | 9.1M | 4.0M |
| Current ratio | 2.80 | 2.08 | 1.41 | 2.84 | 4.03 | 8.05 | 0.97 | 1.37 | 1.12 | 3.92 |
| Quick ratio | 2.58 | 1.72 | 0.93 | 2.05 | 3.59 | 7.47 | 0.79 | 1.03 | 0.94 | 3.64 |
| Debt / equity | 0.30 | 0.57 | 0.40 | 0.25 | 0.04 | 0.07 | 0.30 | 0.16 | 0.30 | — |
| Equity / assets | 55.0% | 53.2% | 56.5% | 74.3% | 80.5% | 85.0% | 55.3% | 63.7% | 51.7% | 78.7% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | C$7.6M | C$11.3M | C$10.4M | C$16.5M | C$32.4M | C$10.7M | C$12.9M | C$3.5M | C$3.9M | C$3.5M | C$6.2M | C$6.0M |
| Cash & equivalents | C$7.6M | C$11.3M | C$10.4M | C$16.5M | C$4.9M | C$10.7M | C$12.9M | C$3.5M | C$3.9M | C$3.5M | C$6.2M | C$6.0M |
| Short-term investments | — | — | — | — | C$27.5M | — | — | — | — | — | — | — |
| Receivables | C$3.2M | C$3.6M | C$2.3M | C$4.2M | C$2.6M | C$4.8M | C$4.9M | C$5.3M | C$3.5M | C$4.1M | C$4.5M | C$4.7M |
| Inventory | C$611,251 | C$491,168 | C$361,850 | C$531,000 | C$524,000 | C$2.1M | C$1.9M | C$2.0M | C$1.9M | C$2.1M | C$2.5M | C$2.5M |
| Other current assets | C$762,317 | C$796,653 | C$918,657 | C$504,000 | C$699,000 | C$1.2M | C$1.0M | C$1.7M | C$1.7M | C$1.8M | C$1.8M | C$2.3M |
| Total current assets | C$12.2M | C$16.2M | C$13.9M | C$21.7M | C$36.3M | C$18.8M | C$20.7M | C$12.5M | C$11.0M | C$11.5M | C$15.1M | C$15.4M |
| Property, plant & equipment (net) | C$4.0M | C$4.1M | C$3.0M | C$4.2M | C$4.4M | C$16.3M | C$15.7M | C$16.4M | C$16.9M | C$17.2M | C$17.0M | C$11.9M |
| Goodwill & intangible assets | C$0 | C$0 | C$0 | C$0 | C$0 | C$9.3M | C$9.0M | C$30.9M | C$31.3M | C$31.2M | C$46.5M | C$47.9M |
| Long-term investments | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 |
| Other non-current assets | C$1.1M | C$1.1M | C$126,984 | C$128,000 | C$127,000 | C$126,000 | C$90,000 | C$149,412 | C$149,977 | C$86,000 | C$85,000 | C$477,000 |
| Total assets | C$17.3M | C$21.3M | C$17.1M | C$26.1M | C$40.7M | C$44.4M | C$45.5M | C$60.0M | C$59.4M | C$60.0M | C$78.7M | C$75.6M |
| Liabilities | ||||||||||||
| Accounts payable | C$5.4M | C$4.2M | C$2.5M | C$3.4M | C$3.3M | C$5.3M | C$4.4M | C$5.4M | C$4.8M | C$3.5M | C$3.0M | C$2.7M |
| Short-term debt | C$483,199 | C$456,226 | C$315,326 | C$721,467 | C$413,000 | C$1.9M | C$1.7M | C$4.8M | C$4.2M | C$2.7M | C$3.1M | C$954,000 |
| Deferred revenue | C$529,218 | C$1.1M | C$694,900 | C$651,607 | C$777,000 | C$1.1M | C$2.4M | C$1.7M | C$1.3M | C$1.4M | C$2.0M | C$1.6M |
| Total current liabilities | C$6.6M | C$5.8M | C$3.8M | C$5.2M | C$16.7M | C$9.0M | C$8.9M | C$12.4M | C$11.2M | C$8.1M | C$9.1M | C$7.5M |
| Long-term debt | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 |
| Lease obligations | C$3.5M | C$3.5M | C$3.5M | C$3.6M | C$3.7M | C$13.4M | C$12.9M | C$13.3M | C$13.5M | C$13.7M | — | — |
| Other long-term liabilities | C$3.8M | C$3.8M | C$2.3M | C$3.2M | C$3.3M | C$11.8M | C$11.5M | C$14.9M | C$15.3M | C$17.9M | C$19.8M | C$16.0M |
| Total liabilities | C$10.4M | C$9.6M | C$6.1M | C$8.4M | C$20.0M | C$20.8M | C$20.4M | C$27.3M | C$26.4M | C$26.1M | C$28.9M | C$23.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | C$137.8M | C$137.0M | C$101.4M | C$136.2M | C$136.3M | C$136.4M | C$136.4M | C$122.3M | C$120.3M | C$119.8M | C$118.3M | C$117.5M |
| Retained earnings (deficit) | −C$148.9M | −C$142.5M | −C$102.5M | −C$134.9M | −C$131.8M | −C$128.8M | −C$126.6M | −C$105.1M | −C$102.6M | −C$100.3M | −C$82.2M | −C$79.3M |
| Accumulated other comprehensive income | C$3.1M | C$3.1M | C$2.3M | C$3.4M | C$3.3M | C$3.2M | C$2.6M | C$2.8M | C$2.6M | C$2.0M | C$1.5M | C$1.9M |
| Total shareholders' equity | C$6.9M | C$11.7M | C$11.0M | C$17.7M | C$20.7M | C$23.6M | C$25.1M | C$32.7M | C$32.9M | C$33.9M | C$49.8M | C$52.0M |
| Key figures | ||||||||||||
| Total debt | C$3.5M | C$3.5M | C$2.6M | C$3.9M | C$3.7M | C$13.4M | C$12.9M | C$16.4M | C$16.1M | C$14.8M | C$15.7M | C$9.6M |
| Net cash (debt) | C$4.1M | C$7.8M | C$7.8M | C$12.6M | C$28.7M | −C$2.7M | −C$13,000 | −C$12.9M | −C$12.2M | −C$11.4M | −C$9.5M | −C$3.6M |
| Working capital | C$5.6M | C$10.4M | C$10.1M | C$16.5M | C$19.6M | C$9.7M | C$11.8M | C$93,000 | −C$154,000 | C$3.4M | C$6.0M | C$7.9M |
| Tangible book value | C$6.9M | C$11.7M | C$11.0M | C$17.7M | C$20.7M | C$14.3M | C$16.1M | C$1.8M | C$1.6M | C$2.7M | C$3.3M | C$4.2M |
| Shares outstanding | 46.8M | 46.7M | 46.5M | 46.2M | 39.6M | 33.1M | 32.9M | 28.1M | 27.1M | 26.9M | 25.8M | 25.1M |
| Current ratio | 1.84 | 2.80 | 3.67 | 4.19 | 2.17 | 2.08 | 2.32 | 1.01 | 0.99 | 1.41 | 1.66 | 2.04 |
| Quick ratio | 1.63 | 2.58 | 3.33 | 3.99 | 2.10 | 1.72 | 1.99 | 0.71 | 0.66 | 0.93 | 1.18 | 1.42 |
| Debt / equity | 0.50 | 0.30 | 0.24 | 0.22 | 0.18 | 0.57 | 0.51 | 0.50 | 0.49 | 0.44 | 0.32 | 0.18 |
| Equity / assets | 39.9% | 55.0% | 64.3% | 67.8% | 50.9% | 53.2% | 55.2% | 54.4% | 55.3% | 56.5% | 63.3% | 68.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in Canadian dollars as reported (latest annual report filed July 23, 2026); data from EODHD.
HYFT financial position
At the end of fiscal 2026 (April 30, 2026), ImmunoPrecise Antibodies had total assets of C$21.3 million (down 52.0% from a year earlier), total liabilities of C$9.6 million and shareholders' equity of C$11.7 million. It held C$11.3 million in cash and short-term investments against C$3.5 million of debt, a net cash position of C$7.8 million. Its current ratio was 2.80. In the latest quarter (ended July 31, 2026) total assets were C$17.3 million and equity C$6.9 million.
Related: HYFT income statement, HYFT cash flow statement, HYFT key metrics. See the HYFT stock overview for the latest quote and news.
HYFT balance sheet FAQ
What are ImmunoPrecise Antibodies's total assets?
ImmunoPrecise Antibodies reported total assets of C$21.3 million at the end of fiscal 2026 (April 30, 2026), compared with C$44.4 million a year earlier.
How much debt does ImmunoPrecise Antibodies have?
ImmunoPrecise Antibodies had C$3.5 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.30.
How much cash does ImmunoPrecise Antibodies have?
ImmunoPrecise Antibodies held C$11.3 million in cash and short-term investments at the end of fiscal 2026; with C$3.5 million of debt that is net cash of C$7.8 million.
What is ImmunoPrecise Antibodies's book value?
ImmunoPrecise Antibodies's shareholders' equity (book value) was C$11.7 million at the end of fiscal 2026.
What is ImmunoPrecise Antibodies's current ratio?
ImmunoPrecise Antibodies had current assets of C$16.2 million and current liabilities of C$5.8 million, a current ratio of 2.80 (it can cover its short-term obligations).